home / stock / kldo / kldo news

KLDO News and Press, Kaleido Biosciences Inc. From 05/02/19

Stock Information
Company Name: Kaleido Biosciences Inc.
Stock Symbol: KLDO
Market: NYSE
Website: /www.kaleido.com
Menu
KLDO KLDO Quote KLDO Short KLDO News KLDO Articles KLDO Message Board
Get KLDO Alerts

News, Short Squeeze, Breakout and More Instantly...
KLDO - Kaleido Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update

LEXINGTON, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced fi...
KLDO - Biotech Market Update: Q1 2019 in Review

The first quarter of 2019 was robust with activity for the biotechnology industry thanks to merger and acquisitions (M&A) in addition to initial public offerings (IPOs).  Looking back to the end of last year, the biotech sector took a significant hit in terms of stock performance, ...

KLDO - Kaleido Bio's KB195 shows ammonia-reducing effect in preclinical testing

Preclinical tests assessing Kaleido Biosciences' (NASDAQ: KLDO ) Microbiome Metabolic Therapy (MMT) candidate KB195 showed its ability to reduce ammonia in healthy human microbiome samples. The results were presented at The International Liver Congress in Vienna. More news on: Kaleido B...

KLDO - Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress(TM) 2019 (EASL)

LEXINGTON, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today presen...
KLDO - Kaleido Biosciences Announces Key Appointments to Leadership Team

LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announ...

Previous 10 Next 10